Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06033274 · ClinicalTrials.gov registry record
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment
A clinical trial of Tricuspid Regurgitation, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- 800
- Enrollment target
- 20
- Study locations
NCT06033274 is a study of Tricuspid Regurgitation that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 800 participants, above the 489-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (64% higher). The trial reports 20 study locations across 9 states.
The verdict
NCT06033274, a study of Tricuspid Regurgitation, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 20
- Study locations
Study Summary
The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pacemaker implantation, and how such patients are managed. On this background, the TRIPLACE Registry - an investigator-initiated global multicenter registry - is aimed at better understanding the safety and efficacy of orthotopic TTVR.
Conditions Studied
Interventions
- DEVICE Transcatheter Tricuspid Valve Replacement
Study Locations (20)
Other
- Rigshospitalet, Copenhagen University Hospital - Copenhagen
- Centre Hospitalier Universitaire de Lille - Lille
- Clinique Pasteur Toulouse - Toulouse
- Heart and Diabetes Centre, North Rhine-Westphalia (NRW), Ruhr-University - Bad Oeynhausen
- Heart Center Cologne, University of Cologne - Cologne
- Cardiovascular Center (CVC) Frankfurt, Division of Cardiology - Frankfurt
- University Heart and Vascular Center, Department of Cardiology - Hamburg
- University Heart Center, Schleswig-Holstein University - Lübeck
- Medical Clinic and Polyclinic, University Hospital of Munich (LMU Klinikum) - Munich
- San Raffaele University Hospital - Milan
- Centro Cardiologico Monzino IRCCS - Milan
New York
- Columbia University Irving Medical Center - New York
- Montefiore Medical Center - The Bronx
Arizona
- Arizona Heart Hospital (Biltmore Cardiology) - Phoenix
Ohio
- Cleveland Clinic - Cleveland
Oregon
- Oregon Health & Science University - Portland
British Columbia
- St. Paul's Hospital - Vancouver
Ontario
- St Michael's Hospital, University of Toronto - Toronto
Quebec
- Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada - Québec
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2023-10-05 |
| Est. Completion | 2026-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06033274
The ClinicalTrials.gov registry entry for NCT06033274 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 489-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (64% higher). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tricuspid Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which Transcatheter Tricuspid Valve Replacement is the first listed.
NCT06033274 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Other, New York, Arizona.
Frequently Asked Questions
What is clinical trial NCT06033274 about?
NCT06033274 is a clinical study titled "Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment". The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pa...
What is the current status of trial NCT06033274?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2023-10-05. Estimated completion is 2026-08.
What conditions does trial NCT06033274 study?
This clinical trial studies the following conditions: Tricuspid Regurgitation.
What interventions are being tested in trial NCT06033274?
The interventions under investigation include: Transcatheter Tricuspid Valve Replacement (DEVICE).
Who is sponsoring clinical trial NCT06033274?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06033274 being conducted?
This trial has 20 study locations across Arizona, New York, Ohio, Oregon, British Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tricuspid Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
RECRUITING
-
TTVR Early Feasibility Study
RECRUITING · NA
-
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
RECRUITING · NA
-
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
RECRUITING · NA
-
TTVR STRONG Under Coverage With Evidence Development (CED) Study
RECRUITING
-
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.